Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
ESMO 2024
Questions discussed in this category
With the presentation of HypoG-01 phase III UNICANCER trial at ESMO 2024, should hypofractionated radiotherapy be the standard across the board for breast cancer?
1 Answer available
21234
Papers discussed in this category
N. Engl. J. Med., 1997-10-02
Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer.
N. Engl. J. Med., 2010-02-11
Long-term results of hypofractionated radiation therapy for breast cancer.
Eur. J. Cancer, 2015-03-01
Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a phase 3 randomised controlled trial.
Lancet, 2019 Dec 14
Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial.
Related Topics
Breast Cancer
Radiation Oncology